Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Pala

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
Cancer|September 17, 2025
Avelumab combined with axitinib for patients with advanced thymoma B3 and thymic carcinomaFabio Conforti, Laura Pala, Chiara Catania, et al.
Cancer Cell|March 11, 2025
Sex hormones, the anticancer immune response, and therapeutic opportunitiesFabio Conforti, Laura Pala, Diletta Di Mitri, et al.
Breast Cancer Research : BCR|January 1, 2020
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrenceFabio Conforti, Laura Pala, Eleonora Pagan, et al.
Acta Diabetologica|January 28, 2022
Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS)Ilaria Dicembrini, Valentina Vitale, Claudia Cosentino, et al.
Cancer Treatment Reviews|November 21, 2024
Estrogen Signaling in Early-Stage Breast Cancer: Impact on Neoadjuvant Chemotherapy and ImmunotherapyChiara Corti, Busem Binboğa Kurt, Beyza Koca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2023
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future ResearchFabio Conforti, Laura Pala, Tommaso De Pas, et al.
Breast (Edinburgh, Scotland)|March 10, 2023
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trialsLaura Pala, Tommaso De Pas, Eleonora Pagan, et al.
JAMA Network Open|August 16, 2022
Association of Anticancer Immune Checkpoint Inhibitors With Patient-Reported Outcomes Assessed in Randomized Clinical Trials: A Systematic Review and Meta-analysisLaura Pala, Isabella Sala, Chiara Oriecuia, et al.
Head & Neck|February 6, 2016
Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancerSalvatore Alfieri, Carla I Ripamonti, Sara Marceglia, et al.
Seminars in Oncology|March 26, 2023
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysisLaura Pala, Tommaso De Pas, Eleonora Pagan, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Cancer|September 17, 2025
Avelumab combined with axitinib for patients with advanced thymoma B3 and thymic carcinomaFabio Conforti, Laura Pala, Chiara Catania, et al.
Cancer Cell|March 11, 2025
Sex hormones, the anticancer immune response, and therapeutic opportunitiesFabio Conforti, Laura Pala, Diletta Di Mitri, et al.
Breast Cancer Research : BCR|January 1, 2020
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrenceFabio Conforti, Laura Pala, Eleonora Pagan, et al.
Acta Diabetologica|January 28, 2022
Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS)Ilaria Dicembrini, Valentina Vitale, Claudia Cosentino, et al.
Cancer Treatment Reviews|November 21, 2024
Estrogen Signaling in Early-Stage Breast Cancer: Impact on Neoadjuvant Chemotherapy and ImmunotherapyChiara Corti, Busem Binboğa Kurt, Beyza Koca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2023
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future ResearchFabio Conforti, Laura Pala, Tommaso De Pas, et al.
Breast (Edinburgh, Scotland)|March 10, 2023
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trialsLaura Pala, Tommaso De Pas, Eleonora Pagan, et al.
JAMA Network Open|August 16, 2022
Association of Anticancer Immune Checkpoint Inhibitors With Patient-Reported Outcomes Assessed in Randomized Clinical Trials: A Systematic Review and Meta-analysisLaura Pala, Isabella Sala, Chiara Oriecuia, et al.
Head & Neck|February 6, 2016
Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancerSalvatore Alfieri, Carla I Ripamonti, Sara Marceglia, et al.
Seminars in Oncology|March 26, 2023
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysisLaura Pala, Tommaso De Pas, Eleonora Pagan, et al.
Pageof 13